It has been reported that the presence of undetectable micrometastases in the liver in patients with KRAS mutation predisposes them to R1 resection with parenchymal preservation and to reduced OS in patients with tumor recurrence in the residual liver.30 The gene discussed is KRAS; the disease is neoplasm.